That is, AxD, which belongs to monogenic neurological diseases, has a broader AAO than previously thought, suggesting the existence of modifier genes other than causative GFAP mutations contributing to the diversity of AAO, especially in the bulbospinal type and intermediate form. Here, GFAP is linked to nervous system disorder.